<unk>  immune Fab used to treat<unk>  The primary treatment of<unk>  is<unk>  immune fab, which is an antibody made up of anti-digoxin immunoglobulin fragments. This antidote has been shown to be highly effective in treating life-threatening signs of<unk>  such as hyperkalemia, hemodynamic instability, and arrhythmias. Fab dose can be determined by two different methods. First method is based on the amount of<unk>  ingested whereas the second method is based on the serum<unk>  concentration and the weight of the person. Other treatment that may be used to treat life-threatening arrhythmias until Fab is acquired are magnesium, phenytoin, and lidocaine. Magnesium suppresses<unk> -induced ventricular arrhythmias while phenytoin and lidocaine suppresses<unk> -induced ventricular automaticity and delay afterdepolarizations without depressing AV conduction. In the case of an abnormally slow heart rate (bradyarrhythmias), Atropine, catecholamines (isoprenaline or salbutamol), and/or temporary cardiac pacing can be used.
Digoxin toxicity
Beta blocker
Tachycardia-induced cardiomyopathy
Hyperkalemia
Drug-induced QT prolongation
Hypothyroidism
Uremic pericarditis
Acute coronary syndrome